Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SLC17A8 encodes a vesicular glutamate transporter. Additionally we are shipping SLC17A8 Antibodies (55) and and many more products for this protein.
Vesicular glutamate transporter 3 is expressed preferentially in hair cells of the ear, and is required for synaptic transmission in the hair cells in zebrafish.
Results reveal that VGLUT3 plays an important role in the development of l-DOPA-induced dyskinesia (LID), and should be considered as a potential and promising therapeutic target for prevention of LID
Synaptic excitation of W3 ganglion cells is diminished, and responses to object motion are suppressed in mice lacking VGluT3.
Measurements of time spent in noisy versus attenuated environments reveal noise-avoidance behavior in mice expressing VGLUT3 whereas Vglut3-/- mice showed no preference.
Transient expression of VGLUT3 by a discrete population of neurons in the dorsal horn is required for mechanical pain.
Results showed that VGLUT3 expression has little or no effect on vesicular synergy at the immature glycinergic synapse of brainstem
The possible contribution of VGLUT3 upregulation in the cochlear degeneration is discussed.
Our data demonstrate that VGLUT3 is required for normal cholinergic signaling onto striatal fast-spiking interneurons, as well as for acetylcholine-dependent disynaptic inhibition of medium spiny neurons.
This study demonistrated that vglut3 are present in synaptic vesicles in acetylcholinergic nerve terminals in the striatum.
VGLUT3 contributes to protection against neonatal hypoxic stress
The physiological properties and anatomical features of the VGLUT3+ amacrine cells suggest that this bistratified interneuron may play a role in disinhibitory signaling.
The results of this study identify VGLUT3 as an unexpected regulator of drug abuse.
The results from our study suggest that the p.M206Nfs*4 mutation in the SLC17A8 gene is likely a pathogenic mutation that causes autosomal dominant non-syndromic hearing loss.
The absence of VGLUT3 in transgenic mice leads to an up-regulation of the midbrain dopamine system and ameliorates motor dysfunction in a model of Parkinson's disease.
human vesicular glutamate transporter 3 was cloned, shows 72% identity to both hVGLUT1 and hVGLUT2, and its expression in brain overlaps with hVGLUT1 and hVGLUT2
Docking and homology modeling explain the inhibition of VGLUT3.
VGLUT3 immunoreactivity covered only a limited portion of the possible Glu (show DCTN1 ELISA Kits)-ergic pathways in the human fetal small intestine.
SLC17A8 encodes vesicular glutamate transporter-3, VGLUT3 and its impairment has a role in nonsyndromic deafness DFNA25 and inner hair cell dysfunction
This gene encodes a vesicular glutamate transporter. The encoded protein transports the neurotransmitter glutamate into synaptic vesicles before it is released into the synaptic cleft. Mutations in this gene are the cause of autosomal-dominant nonsyndromic type 25 deafness. Alternate splicing results in multiple transcript variants.
vesicular glutamate transporter 3
, solute carrier family 17 member 8
, vesicular glutamate transporter-3
, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8